12:00 AM
 | 
May 01, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Anti-epidermal growth factor receptor regulatory update

IMCL received notice of allowance for a U.S. patent covering the combination of monoclonal antibodies that inhibit the binding of...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >